| Document |
Document Title |
|
WO/2024/090156A1 |
A smell identification method according to the present invention includes: (a) a step for adsorbing smell molecules included in a sample gas onto a first sensor (8a), a second sensor (8b), and a third sensor (8c) at different times durin...
|
|
WO/2024/091930A1 |
The disclosure provides methods and systems for sample screening which may involve screening samples in presence and/or absence of effectors (e.g., encoded effector/compound libraries) for their potential effects on the sample and/or a t...
|
|
WO/2024/091991A1 |
The invention provides methods of dosing for the treatment of cancers, such as multiple myelomas, with anti-fragment crystallizable receptor-like 5 (FcRH5)/anti-cluster of differentiation 3 (CD3) bispecific antibodies.
|
|
WO/2024/091556A1 |
Methods for identifying biomarkers indicative of an increased risk for developing hepatic encephalopathy (HE) following transjugular intrahepatic portosystemic shunting (TIPS) are provided. Methods include determining whether the subject...
|
|
WO/2024/090265A1 |
This information processing device 1 comprises: a storage unit 12 which stores a prognosis estimation model that has been trained to output the prognosis of a patient upon receiving input data including a spatial distribution of at least...
|
|
WO/2024/088627A1 |
The invention relates to a method for determining the type and/or the concentration of an oxidizable gas component in an oxygen-containing gas mixture using a measuring device which comprises at least one first sensor element (20), where...
|
|
WO/2024/091527A1 |
Methods of using a separation media to isolate a target molecule that includes a carbohydrate are disclosed. The separation media includes a support substrate and a plurality of separation ligands immobilized on the support substrate. Th...
|
|
WO/2024/089438A1 |
The disclosure concerns a method of analysing a sample comprising an intact membrane protein, in a sample comprising non-synthetic biological membrane material. The method involves irradiating a gas phase proto membrane protein ion with ...
|
|
WO/2024/091900A1 |
Systems, methods, and compositions can be used for separating, isolating and/or selecting cells. The methods can utilize beads and/or matrices that bind cells. The beads and/or matrices can be dissolvable. The disclosed systems, methods,...
|
|
WO/2024/090832A1 |
The present invention relates to a three-dimensional (3D) neuromuscular junction (NMJ) model co-cultured with muscle bundles derived from skeletal muscle cells (C2C12) and, more specifically, to a 3D neuromuscular junction model prepared...
|
|
WO/2024/091445A1 |
Provided herein are methods for treating cholestasis in a subject having liver disease. More specifically, the present invention relates to methods for treating Progressive Familial Intrahepatic Cholestasis (PFIC) in a subject where the ...
|
|
WO/2024/091060A1 |
According to a method for producing a brain cancer organoid from induced pluripotent stem cells derived from a brain cancer patient, a brain organoid having high production efficiency can be produced using patient-derived induced pluripo...
|
|
WO/2024/086878A1 |
The disclosure relates to a screening system configured to identify biological agents, biological differences, pathogens and/or genetic differences. The screening system may include an incubation zone having an incubation station for inc...
|
|
WO/2024/092035A1 |
The present disclosure provides a nanopore device for processing a fluid sample, comprising: a substrate; a top cavity, wherein the top cavity comprises a first dielectric; a bottom cavity, wherein the bottom cavity comprises a second di...
|
|
WO/2024/006460A9 |
Biomarkers and machine learning techniques to identify biomarkers are disclosed herein. In one particular implementation, the present disclosure relates to the identification of biomarkers to be used in the detection and diagnosis of LD....
|
|
WO/2024/091607A1 |
Provided herein are compositions and methods for cancer diagnosis, research and therapy, including but not limited to, cancer markers. In particular, provided herein are methods of treating renal cancer based on expression levels of canc...
|
|
WO/2024/092165A1 |
Disclosed herein is a method for diagnosing a mycobacterial infection in a subject. The method comprises performing acetonitrile fractionation of a subject sample to deplete depleted in high molecular weight proteins. The sample is enzym...
|
|
WO/2024/090949A1 |
The present invention provides a method and a system for calculating the absorption rate of a predetermined absorbent material from image data obtained by capturing an image of the absorbent material absorbing water. According to the pre...
|
|
WO/2024/092277A1 |
The present application provides systems and methods of characterizing and tracking aging, resilience, dementia, and cognitive decline using brain dynamic biomarkers. The methods and system employ advanced signal processing methods to en...
|
|
WO/2024/088788A1 |
The present invention concerns the diagnosis and assessment of juvenile myelomonocytic leukemia (JMML). In particular, it relates to a method of diagnosing JMML in a subject, the method comprising a) determining the amount of at least on...
|
|
WO/2024/090571A1 |
Provided are: a method for detecting immune-mediated inflammatory diseases characterized by an increase in the expression of MMP12 in a subject; a diagnostic drug containing a substance that specifically interacts with MMP12; and a thera...
|
|
WO/2024/091064A1 |
The present invention relates to a red blood cell-derived magnetic immunoparticle and use thereof. The red blood cell-derived magnetic immunoparticle according to an aspect can minimize side effects in vivo by comprising a red blood cell...
|
|
WO/2024/091509A1 |
A device where saliva from a pregnant woman in the first trimester of pregnancy (6-8 weeks of pregnancy) is mixed with a chaotropic agent that facilitates cell lysis and protein denaturization. The mixture is introduced into a microfluid...
|
|
WO/2024/089293A1 |
The present invention discloses a method of therapeutically treating cancer, in particular CRC (colorectal cancer), or of reducing the risk of cancer in particular CRC, disease progression in a patient comprising expressing miR-326 in th...
|
|
WO/2024/089689A1 |
The presently disclosed subject matter provides methods for diagnosing breast cancer. It relates to the identification of unique T cell receptor (TCR) CDR3 clones whose frequency in the subject's TCR repertoire sequencing data is indicat...
|
|
WO/2024/090669A1 |
An embodiment of a method of managing a pipe by using an ionizing device and a water quality sensor according to the present invention comprises, in a state in which a water quality sensor is provided in a fluid pipe at each of a first l...
|
|
WO/2024/089692A1 |
A scent personalization system that utilize one or more processors and memories to carry out the following: receive user's data indicative of one or more olfactive preferences and/or physiological properties of a user; process the user's...
|
|
WO/2024/089664A1 |
The invention relates to a nanostructured semiconductor material for the detection of carbon dioxide in a large concentrations' interval. Said nanostructured semiconductor material is based on indium oxide doped with sodium (Na:In2O3).
|
|
WO/2024/087430A1 |
An enzyme-linked immunosorbent assay method for quantitatively detecting a urine amyloid precursor protein (APP) fragment. The method comprises: after coupling phagocytosis promoting peptides (PPP) with biotin, detecting an amyloid precu...
|
|
WO/2024/091923A1 |
The present invention relates to methods for monitoring the immune status of a population by detecting and/or quantifying antibodies present in wastewater. The invention further provides methods and kits for monitoring the presence of an...
|
|
WO/2024/091696A1 |
A sensing layer composition is provided. The sensing layer composition is particularly suited to be adhered to at least one side of one or more waveguide channels in/on a waveguide chip of an interferometric system. The sensing layer com...
|
|
WO/2024/089620A1 |
Described herein is a method of preventing or treating a neurodegenerative disease including administering an agent to a person in which the agent causes increase in outflow of cerebrospinal fluid through nasopharyngeal lymphatic plexus ...
|
|
WO/2024/087539A1 |
An enhanced StayGold yellow fluorescent protein and the use thereof, which relate to the technical field of recombinant proteins. With regard to the enhanced StayGold yellow fluorescent protein, the amino acid sequence of StayGold compri...
|
|
WO/2023/214405A9 |
Methods of predicting clinical outcome in a subject suffering from cancer, detecting non-liver cancer in a subject, and methods of treating or preventing cancer or cancer-associated cachexia are provided. Synthetic lipid nanoparticles en...
|
|
WO/2024/091477A1 |
Provided herein is an automated euglobulin clot lysin assay method for calculating a euglobulin clot lysis time from a plasma sample in an amount of less than about 75 μL. Also disclosed here in a kit analyzing the euglobulin clot lysis...
|
|
WO/2024/083169A1 |
The present application relates to a method for analyzing a geological body by means of physical and chemical properties of the geological body, and specifically relates to a method for determining a hydrothermal uranium mine prospect, c...
|
|
WO/2024/082681A1 |
Provided are a fusion protein, and a nucleic acid molecule comprising a nucleotide sequence encoding the fusion protein. The present invention also relates to a vaccine comprising the fusion protein or the nucleic acid molecule. Furtherm...
|
|
WO/2024/086358A1 |
The instant disclosure is directed to separation media, their components, and methods of using such media. A separation medium may comprise a first layer and a second layer, wherein the first layer is fixedly coupled to the second layer....
|
|
WO/2024/059070A9 |
The invention provides a method of producing a population of CD34+ hematopoietic precursor cells. The CD34+ hematopoietic precursor cells are used in methods of producing natural killer (NK), methods of inducing NK cell differentiation f...
|
|
WO/2024/085599A1 |
A urine analysis device according to one embodiment of the present invention comprises: a seating unit into which a urine test kit is seated; a plurality of sensor units provided on the inner surface of the seating unit to irradiate ligh...
|
|
WO/2024/083790A1 |
The present invention proposes an efficient method to prognose the evolution of a solid cancer in a subject in need thereof, by analysing the frequency of a particular subset of dendritic cells as well as their relative number as compare...
|
|
WO/2024/085809A1 |
Disclosed herein is a concrete monitoring system and a concrete monitoring method. The concrete monitoring system, includes at least one piezoelectric aggregate embeddable in a concrete structure; and a controller. The controller is conf...
|
|
WO/2024/085141A1 |
This fluid device comprises a base plate and a wall material provided on the base plate, and includes a plurality of first wells surrounded by the base plate and the wall material, and a plurality of second wells provided respectively in...
|
|
WO/2024/085238A1 |
Provided is a product that enables easy monitoring of early rupture of membranes. A wearing article provided with a test strip using immunochromatography, wherein the test strip is designed to detect amniotic fluid-derived insulin-like g...
|
|
WO/2024/084460A1 |
Provided is a method for detecting a microbe in a sample comprising detecting confluence of the sample. Also provided is a method for assaying a test agent comprising adding the test agent to a sample comprising a microbe, and measuring ...
|
|
WO/2024/082719A1 |
A method for predicting a critical caking period of a crystal particle, comprising the following steps: first, establishing a CHS crystal bridge growth model database of a crystal particle of the same type as a crystal particle to be pre...
|
|
WO/2024/085603A1 |
The present invention relates to a pharmaceutical composition for preventing or treating c-Myc-associated diseases, and use thereof, the composition comprising a preparation that inhibits the expression or activity of ubiquitin-specific ...
|
|
WO/2024/086683A2 |
Provided herein is a peptide array comprising a plurality of flagellin peptides corresponding to highly conserved peptide regions. For example, the peptide array comprises a plurality of Lachnospiraceae flagellin peptides, which can be s...
|
|
WO/2024/083745A1 |
The current invention relates to cell - cell interaction and in particular to cellular avidity. Provided are improved means and methods to study cell - cell interaction and characterizing cellular avidity. Highly advantageously, it was s...
|
|
WO/2024/086700A1 |
Methods and devices are provided for capturing and using quantitative and qualitative results from point-of- collection devices for different diagnostic assays on a mobile device application. In one nonlimiting embodiment, these methods ...
|
